GNI Group (FRA:3G6) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 27, 2026)


FRA:3G6 GNI Group Ltd FRA:3G6
83 GF Score
Price €13.20
GF Value €14.61
! 5 Warning Signs
View Full Analysis

What is GNI Group Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

GNI Group's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

FRA:3G6 vs VRTX, REGN, ALNY: Margin of Safety % (DCF Earnings Based) Comparison

For the Biotechnology subindustry, GNI Group's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GNI Group Margin of Safety % (DCF Earnings Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GNI Group's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where GNI Group's Margin of Safety % (DCF Earnings Based) falls into.


FRA:3G6
83GF Score
GNI Group Ltd FRA:3G6
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is GNI Group (FRA:3G6) Overvalued in 2026?

Based on GuruFocus' analysis, GNI Group stock appears to be undervalued. The current stock price of €13.20 is trading 9.7% below its estimated GF Value™ of €14.61.

Key valuation signals for FRA:3G6:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: €14.61 vs. price of €13.20 (9.7% below fair value)
  • GF Score™: 83/100 with 5 warning signs

No single metric tells the full story. See the FRA:3G6 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

GNI Group Business Description

Other Exchanges 2160:Japan
Address 2-2-2 Nihonbashi Honcho, 3rd Floor, Nihonbashi Honcho YS Building, Chuo-ku, Tokyo, JPN, 103-0023
GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.
83GF Score

Get the complete analysis for FRA:3G6

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€13.20
Price
€14.61
GF Value